tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LXEO Stock Latest News

Lexeo Therapeutics Announces Head of Research Transition
Company AnnouncementsLexeo Therapeutics Announces Head of Research Transition
15d ago
8K
LXEO
Lexeo Therapeutics Announces Key Executive Leadership Changes
PremiumCompany Announcements
Lexeo Therapeutics Announces Key Executive Leadership Changes
24d ago
8K
LXEO
Lexeo appoints Narinder Bhalla as CMO, Eric Adler as CEO, Myoventive
PremiumThe Fly
Lexeo appoints Narinder Bhalla as CMO, Eric Adler as CEO, Myoventive
24d ago
LXEO
Lexeo appoints Jose Manuel Otero as COO
PremiumThe Fly
Lexeo appoints Jose Manuel Otero as COO
24d ago
LXEO
Lexeo Therapeutics price target lowered to $10 from $13 at H.C. Wainwright
PremiumThe Fly
Lexeo Therapeutics price target lowered to $10 from $13 at H.C. Wainwright
1M ago
LXEO
Lexeo Therapeutics Reports Positive Interim HEROIC-PKP2 Trial Results
PremiumCompany AnnouncementsLexeo Therapeutics Reports Positive Interim HEROIC-PKP2 Trial Results
1M ago
8K
LXEO
Lexeo Therapeutics Inc trading resumes
Premium
The Fly
Lexeo Therapeutics Inc trading resumes
1M ago
LXEO
Lexeo Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Lexeo Therapeutics Inc trading halted, volatility trading pause
1M ago
LXEO
Lexeo announces preliminary data from HEROIC-PKP2 Phase I/II trial
PremiumThe Fly
Lexeo announces preliminary data from HEROIC-PKP2 Phase I/II trial
1M ago
LXEO
Lexeo Therapeutics announces research collab with Johnson & Johnson
PremiumThe Fly
Lexeo Therapeutics announces research collab with Johnson & Johnson
1M ago
JNJ
LXEO
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Raymond James Sees an Attractive Setup in These 2 ‘Strong Buy’ Stocks
2M ago
LXEO
PHAT
Lexeo Therapeutics initiated with a Strong Buy at Raymond James
PremiumThe Fly
Lexeo Therapeutics initiated with a Strong Buy at Raymond James
2M ago
LXEO
Tenaya Therapeutics price target lowered to $8 from $9 at Chardan
PremiumThe FlyTenaya Therapeutics price target lowered to $8 from $9 at Chardan
2M ago
LXEO
RCKT
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
LXEO
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Lexeo Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
LXEO
Optimistic Buy Rating for Lexeo Therapeutics Driven by High-Dose Potential and Superior Safety Profile
PremiumRatings
Optimistic Buy Rating for Lexeo Therapeutics Driven by High-Dose Potential and Superior Safety Profile
3M ago
LXEO
Lexeo Therapeutics Reports Decreased Losses and Strong Cash Position
PremiumCompany Announcements
Lexeo Therapeutics Reports Decreased Losses and Strong Cash Position
4M ago
LXEO
Lexeo Therapeutics files to sell 1.25M shares of common stock for holders
PremiumThe Fly
Lexeo Therapeutics files to sell 1.25M shares of common stock for holders
4M ago
LXEO
Lexeo Therapeutics reports Q3 EPS (33c), consensus (44c)
PremiumThe Fly
Lexeo Therapeutics reports Q3 EPS (33c), consensus (44c)
4M ago
LXEO
Lexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright
PremiumThe FlyLexeo Therapeutics selloff looks ‘highly unwarranted,’ says H.C. Wainwright
4M ago
LXEO
Lexeo Therapeutics Advances Study on Friedreich Ataxia-Associated Cardiomyopathy
Premium
Company Announcements
Lexeo Therapeutics Advances Study on Friedreich Ataxia-Associated Cardiomyopathy
4M ago
LXEO
Lexeo Therapeutics Advances Gene Therapy Study for Genetic Heart Condition
Premium
Company Announcements
Lexeo Therapeutics Advances Gene Therapy Study for Genetic Heart Condition
4M ago
LXEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >